SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-019094
Filing Date
2022-05-10
Accepted
2022-05-10 08:47:16
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-8k_20220510.htm   iXBRL 8-K 38465
2 EX-99.1 lyra-ex991_24.htm EX-99.1 201642
3 GRAPHIC g3lbc3eihy1c000001.jpg GRAPHIC 23956
  Complete submission text file 0001564590-22-019094.txt   419579

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lyra-20220510.xsd EX-101.SCH 5709
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20220510_lab.xml EX-101.LAB 19410
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20220510_pre.xml EX-101.PRE 11591
8 EXTRACTED XBRL INSTANCE DOCUMENT lyra-8k_20220510_htm.xml XML 3542
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 22907543
SIC: 3841 Surgical & Medical Instruments & Apparatus